Ginkgo Bioworks And SaponiQx Awarded a 5-Year MCDC Contract Totaling Up To $31M To Discover and Manufacture Next-Generation Vaccine Adjuvants Using Generative Molecular Design
Company Profile
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.